Publication | Closed Access

Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response

Neck CancerOncologyMedicineCytochrome P450 2C9PharmacotherapyHead And Neck CancerAnti-cancer AgentMetabolomicsCytochrome P450 2D6PharmacologyRadiation OncologyTreatment ResistancePharmacokineticsCancer ResearchDrug DiscoveryNeck Oncology